Mediwound Ltd (MDWD)

[midastouch017]

MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates

https://finance.yahoo.com/news/mediwound-mdwd-reports-q1-loss-123512069.html

MediWound (MDWD) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 16.67%. A quarter ago, it was expected that this developer of treatments for burns and hard-to-heal wounds would post a loss of $0.11 per share when it actually produced a loss of $0.06, delivering a surprise of 45.45%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

MediWound, which belongs to the Zacks Medical - Drugs industry, posted revenues of $5.85 million for the quarter ended March 2021, surpassing the Zacks Consensus Estimate by 10.32%. This compares to year-ago revenues of $4.44 million. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

MediWound shares have added about 26.5% since the beginning of the year versus the S&P 500's gain of 10.9%.